CorePath Partners with Cizzle Biotech to Develop Early Lung Cancer Detection Test
CorePath is partnering with Cizzle Biotechnology to develop and offer a proprietary early-stage lung cancer blood test for the U.S.
Read More
Search Results for: lung cancer
4 Critical Steps to Optimize Cancer Diagnosis
Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
Read More
Researchers Develop a Novel AI Algorithm for Digital Pathology Analysis
Researchers developed a novel AI algorithm to classify lung cancer subtype based on lung tissue images from resected tumors.
Read More
Researchers Find Tumor-Based Methylation Patterns as Cancer Biomarkers
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Read More
Delfi Diagnostics Enters into Research Agreement with Cancer Center
Delfi Diagnostics has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center’s Biomarker Development Program.
Read More